 ?您的位置：對照品 > 標準物質 > 計量院標準物質 > |
|
|
|
| 產品基本信息 |
|
| 產品編號：N900200 |
| 產品名稱：NS-2028 |
| 產品CAS：204326-43-2 |
| 規(guī)格含量：5mg |
| 產品價格：面議 |
| 聯系我們: |
 |
|
 |
|
|
| 產品詳細介紹 |
| 標準品編號: |
N900200 |
| 名稱: |
NS-2028 |
| 別名: |
8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one; |
| CAS號: |
204326-43-2 |
| 分子式: |
C?H?BrN?O? |
| 外觀: |
白色固體 |
| 熔點: |
160-163°C |
| 分子量: |
269.05 |
| 儲存: |
冰箱 |
| 溶解度: |
Chloroform, DMSO, Methanol |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
NS-2028 potent soluble guanylyl cyclase (sGC) inhibitor (Ki = 8 nM). NS-2028 blocks sGC activity in murine cerebellum induced by S-nitroso-glutathione and NMDA. NS-2028 inhibits VEGF-induced cGMP accumulation; abolishes VEGF-induced migration in postcapillary venular endothelial cells (CVEC). |
| 參考文獻 |
|
|
|
|
|
|
|
|
